Report Overview
Summary
Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include BMS and DES stents, self apposing coronary stent systems, SES stents; self-apposing bare metal stents and drug eluting stent, and aspiration catheter stents, among others. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.
Stentys SA (STNT) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Stentys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Stentys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Stentys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Stentys SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Stentys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Stentys SA, Medical Equipment, Deal Details 11
Partnerships 11
Stentys Enters into Distribution Agreement with Micell for MiStent SES 11
Equity Offering 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 11
Stentys Announced Private Placement Of Shares 13
Stentys Completes Rights Issue Of Shares For US$47.3 Million 14
Stentys Completes Private Placement Of Shares For US$11 Million 15
Acquisition 16
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 16
Stentys SA - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 21
Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 22
Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at €7.3 Million 23
Sep 15, 2016: STENTYS Reports 2016 First-Half Results 24
Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 26
Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 27
Mar 16, 2016: STENTYS Reports 2015 Annual Results 28
Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 29
Corporate Communications 30
Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 30
Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO 31
Product News 32
May 24, 2017: STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes 32
Mar 21, 2016: STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease 33
Feb 29, 2016: STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention 34
Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication 35
Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress 36
Product Approvals 37
Mar 21, 2016: STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease 37
Clinical Trials 38
Feb 29, 2016: STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Stentys SA, Medical Equipment, Key Facts, 2016 1
Stentys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Stentys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Stentys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Stentys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Stentys SA, Deals By Market, 2011 to YTD 2017 9
Stentys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Stentys Enters into Distribution Agreement with Micell for MiStent SES 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 11
Stentys Announced Private Placement Of Shares 13
Stentys Completes Rights Issue Of Shares For US$47.3 Million 14
Stentys Completes Private Placement Of Shares For US$11 Million 15
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 16
Stentys SA, Key Competitors 18
Stentys SA, Key Employees 19
Stentys SA, Subsidiaries 20
List of Figures
Stentys SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Stentys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Stentys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Stentys SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Stentys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Stentys SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Stentys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Stentys SA, Medical Equipment, Deals by Market, 2011 to YTD 2017 9